PKM and non-small cell lung carcinoma: Collectively, these findings show that pY105-PKM2 is a critical regulator of stem-like properties in NSCLC, driving increased expression of stemness markers, enhanced tumorigenicity, and chemoresistance in vitro and in vivo.